ASP.L Regulatory News (ASP)

10 May 2005 07:00

Ascribe plc10 May 2005 10th May 2005 Ascribe plc Board Appointments Ascribe plc, the health IT group focusing on medicines management, todayannounces the appointments of Chris Moore to the Board as non-executive Chairmanand Mark Woodbridge as non-executive director, with immediate affect. Chris Moore, aged 50, is currently Chief Executive of Torex Retail plc andChairman of retail IT services group XN Checkout. He has extensive plc expertisewith over 20 years experience within the IT sector. Up until its merger withiSOFT, Chris led the management team of the high profile European healthcare ITgroup, Torex PLC, where he built up the company by acquisition and organically,from a small company with a market capitalisation of £10 million to a £350million substantial group. Mark Woodbridge, aged 34, was Group Finance Director of Torex PLC from June 2000to December 2003, working alongside Chris during the group's transformation froma small company to a market leader. Previously Mark worked as FinancialController for Tarmac plc for five years, two of which were spent in Malaysia. Commenting on the appointments, Steve Crichlow, Chief Executive, Ascribe plc,said: "Following our successful listing on AIM in December, the Company hascontinued to perform well and is now at the next stage of strategic positioningand corporate development. Therefore, we are very pleased to welcome Chris andMark to the Board of Ascribe plc, both of whom have a wealth of managerial andbusiness experience which will prove invaluable to us in the forthcoming years." Commenting on the appointments, Chris Moore said: "Ascribe is a market leadingcompany, with an excellent product strategy and great potential in the highgrowth medicines management sector. We are delighted to be given the opportunityof working with the team on developing future growth strategy and ensuringAscribe's continued success." Contacts: Ascribe plc Steve Crichlow Chief Executive Tel: +44 (0) 161 280 8080 Citigate Dewe Rogerson Ginny Pulbrook / Justin Griffiths Tel: +44 (0) 207 638 9571 Chris Moore Save as disclosed below, there is nothing further to disclose in relation toChris Moore's appointment under schedule two, paragraph (f) of the AIM Rules. Past directorships: Associated Packaging Limited Brandexpert Limited Chavignol (Wines) Limited Ambridge Medical Systems Limited iSOFT Group plc Latique Travel Limited Oldham Athletic Association Football Club Limited Oldham Athletic Stadium Company Limited Omicron Electron Spectroscopy Limited Smart Terminals Limited Torex Group Limited ( Torex Health (Germany) Limited Torex Hire Limited Torex plc Current directorships: Associated Technologies Limited AT Air Limited Chavignol Limited DVD.CO.UK Limited Flow System Technologies Limited Heskgold Limited Intergarage 3000 UK Limited Lytham Enterprises Omicron Nanotechnology Limited Speed 8765 Limited The Torex Foundation Torex Retail plc XN Checkout Holdings plc As at 4 May 2005, Chris Moore has a notifiable interest in the ordinary sharecapital of the Company of 10,822,771 shares, representing 10.46% of the issuedshare capital of the Company. Mark Woodbridge Save as disclosed below, there is nothing further to disclose in relation toMark Woodbridge's appointment under schedule two, paragraph (f) of the AIMRules. Past directorships: iSOFT plc Torex PLC Current directorships: Woodstock developments ltd TTCC Ltd Vericheq Limited Flowsystems Technologies Limited DW Retail Group Ltd As at 4 May 2005, Mark Woodbridge has a notifiable interest in the ordinaryshare capital of the Company of 30,000 shares, representing 0.029% of the issuedshare capital of the Company. Notes to Editors: Ascribe is a health IT group focusing on medicines management through thedevelopment and marketing of software solutions supporting patient, clinical andbusiness processes to the international healthcare market. The Group consistsof ASC Computer Software Limited, a software supplier to hospital pharmacydepartments internationally and Protechnic Exeter Limited, a provider ofsoftware solutions to the primary healthcare market. Ascribe joined AIM on 17December 2004 raising £5.5m before expenses. The software produced by Ascribe addresses the Audit Commission report 'ASpoonful of Sugar' published in 2001, which identified potentially up to 1,200lives and £500 million per year from certain medication errors in UK hospitalsalone could be saved using clinical information systems. Ascribe's systemenables pharmacists to store information about the patients they treat and usethis information to assist in their decision-making. The system also integrateswith stock control procedures. The latest web based product has further enabledtechnology to link the information between customers building a solution wherethe risk of the above medication errors can be reduced. Protechnic Exeter supports those who provide care within Primary Care,Community, Mental Health and Social Care. Its ePEX software is widely usedthroughout the United Kingdom and Ireland to provide specialist mental healthsystems to support the administration, clinical management and informationactivities of the Trusts; and child care systems for interactive scheduling forvaccinations, immunisations and surveillance, providing a longitudinal record ofpatients from birth into adulthood for all community services. Its Exetersoftware is widely used by UK GP practices. After considerable investment in web based solutions, the Group's strategy is touse this software to enhance its offering, initially to Protechnic Exetercustomers and then to customers of other acquisitions as they are completed andintegrated, delivering a Group capable of addressing the whole medicinesmanagement market. For further information, please visit: www.ascribe.com This information is provided by RNS The company news service from the London Stock Exchange